Latest Rhinology Stories

Regulatory News: Meda AB (STO:MEDAA): The registration application for azelastine nasal spray in the new formulation with Extra Strength has been submitted to the US Food and Drug Administration (FDA), seeking approval to treat symptoms of Seasonal Allergic Rhinitis and Perennial Allergic Rhinitis. The new formulation is patent pending. Six phase III studies evaluating efficacy and safety and a long term safety have been conducted involving about 1,600 patients treated with azelastine...

There is a link between alcohol consumption and increased risk of perennial allergic rhinitis -- runny nose -- Danish researchers said. The study of 5,870 young adult women, published in the Clinical and Experimental Allergy, found the risk increased 3 percent for every additional alcoholic drink per week. In contrast, lead author Dr. Janne Tolstrup of the National Institute of Public Health in Denmark, did not observe any increase in risk of seasonal allergic rhinitis according to alcohol...

SANTA ROSA, Calif., July 30 /PRNewswire/ -- While summer is the time of year people like to spend most of their day outside, summer allergens keep many sinus sufferers from enjoying activities such as barbequing, hanging out at the pool and spending time in the park, to name a few. In fact, a new survey of more than 1,000 consumers shows that one-third of sinus sufferers say they miss or cut short social outings or business engagements because of their symptoms. With ragweed season right...

By Thomas Lee, Star Tribune, Minneapolis Jul. 14--Doctors use balloon catheters to open clogged arteries. Now, one local start-up hopes to apply the same technology to people who have clogged sinuses. Entellus Medical Inc., based in Maple Grove, has developed what it bills as a cheaper and less invasive away to treat sinusitis, or severe chronic sinus infections. The procedure involves inserting a balloon catheter into the nasal cavity through a tiny incision under the lip, expanding the...

Doctors use balloon catheters to open clogged arteries. Now, one local start-up hopes to apply the same technology to people who have clogged sinuses. Entellus Medical Inc., based in Maple Grove, has developed what it bills as a cheaper and less invasive away to treat sinusitis, or severe chronic sinus infections. The procedure involves inserting a balloon catheter into the nasal cavity through a tiny incision under the lip, expanding the balloon in the passageway and draining excess mucus...

Morria Biopharmaceuticals has initiated a Phase II equivalent study of MRX-4, in a nasal aerosol formulation, in 105 patients suffering from allergic rhinitis. The two-arm, randomized, multi-dose, double-blind, placebo-controlled study includes Rhinocort as the steroid comparator arm. The study is expected to be completed by the end of third quarter 2008. The study is designed to evaluate the safety, tolerability, and efficacy of intranasal MRX-4 in allergic rhinitis (AR) patients outside...

Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announced today that continued analysis of the unblinded full data set on its pivotal Fast-Tracked Phase 3 Trial of SinuNase™ (topical amphotericin B 0.01% suspension) for chronic sinusitis has demonstrated that among patients with objective evidence of more intense inflammation in chronic sinusitis at the time of enrollment, the efficacy of SinuNase compared to control lavage in reducing inflammation is statistically significant....

Sepracor Inc. (Nasdaq: SEPR) today announced that OMNARIS™ (ciclesonide) Nasal Spray is now available by prescription in pharmacies nationwide. OMNARIS Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children 6 years of age and older, and with perennial allergic rhinitis in adults and adolescents 12 years of age and older. "We believe that OMNARIS Nasal Spray is a strategically seamless fit with our proprietary...

MENLO PARK, Calif., April 14 /PRNewswire/ -- Two independent studies published this week in American Journal of Rhinology and Annals of Otology, Rhinology, & Laryngology confirm Balloon Sinuplasty(TM) technology safely opens narrow sinuses, is economical and highly satisfactory to chronic sinusitis patients. The peer-reviewed studies analyzed outcomes of more than 1,100 individuals treated with this minimally-invasive balloon technology from Acclarent, a leading developer of innovative...

Ready for allergies? Tree pollen is in the air and grass pollen isn't far behind. That means it's time to start taking antihistamines if you have seasonal allergies, even if you don't have symptoms yet, said Wichita allergist Joel Fromer of the Allergy and Asthma Center. "The earlier you start your medications, the better off you will be," Fromer said Monday. "Antihistamines can't possibly keep up" once symptoms appear. "I tell my patients to start their allergy...